THE RELATION BETWEEN METHOD OF ADMINISTRATION, ROUTE OF ABSORPTION, INHIBITORY ACTIONS AND ACUTE TOXICITY OF ARECOLINE HYDROBROMIDE IN DOGS.
D000042:Absorption; D001115:Arecoline; D001794:Blood Pressure; D004285:Dogs; D004304:Dosage Forms; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008660:Metabolism; D010277:Parasympathomimetics; D010600:Pharmacology; D012106:Research; D012119:Respiration; D013607:Tablets; D014116:Toxicology; D014730:Veterinary Medicine
D004304:Dosage Forms; D010277:Parasympathomimetics; D013607:Tablets; D001115:Arecoline
ABSORPTION; BLOOD PRESSURE; DOGS; DOSAGE FORMS; EXPERIMENTAL LAB STUDY; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; METABOLISM; PARASYMPATHOMIMETICS; PHARMACOLOGY; RESPIRATION; TABLETS; TOXICOLOGIC REPORT; VETERINARY MEDICINE